Chemeq denies disclosure claims
AUSTRALIA - Troubled Perth biotech Chemeq has been accused by the corporate regulator of failing to comply with continuous disclosure rules. The charges, which carry individual fines ranging between $200,000 and $1 million, relate to a South African sales contract, new plant construction costs, funding needs, and a US patent extension.
24 December 2004
2 minute read
